Merck & Co., Inc. Share Price
NYSE: MRKHealthcare
Live Merck & Co., Inc. Share Price Chart
O H L
Merck & Co., Inc. Performance Overview
Days Range
▼
$145.79Low
$147.70High
Markets Today
| Previous Close | $147.15 |
|---|---|
| Open | $146.73 |
| Volume | 6,572,502 |
| Day's Range | $145.79 - $147.70 |
| 52W Range | $77.58 - $156.92 |
| Market Cap | $363.04 B |
Historical Performance
| 1M Returns | -3.50 |
|---|---|
| 3M Returns | +28.98 |
| 6M Returns | +28.61 |
| 1Y Returns | +80.19 |
| 5Y Returns | +104.18 |
| 10Y Returns | +139.47 |
Merck & Co., Inc. Fundamentals
| Market Cap | $363.04 B |
|---|---|
| Dividend yield | 2.31 |
| PE Ratio | 117.53 |
| PEG Ratio | N/A |
| Revenue | $65.01 B |
| ROE TTM | 0.37 |
| EPS TTM | $1.25 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 8.66 |
| EBITDA | $27.95 B |
| Profit Margin | 28.08 |
| Market Cap | $363.04 B |
|---|---|
| Dividend yield | 2.31 |
| PE Ratio | 117.53 |
| PEG Ratio | N/A |
| Revenue | $65.01 B |
| ROE TTM | 0.37 |
| EPS TTM | $1.25 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 8.66 |
| EBITDA | $27.95 B |
| Profit Margin | 28.08 |
Merck & Co., Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $15.53 B | $15.81 B | $17.28 B | $16.40 B | $16.29 B | $16.61 B |
| Gross Profit + | $12.11 B | $12.25 B | $13.42 B | $10.85 B | $12.09 B | $12.21 B |
| Operating Income | $5.87 B | $4.99 B | $6.51 B | $3.85 B | -$3.40 B | -$584.00 M |
| EBITDA | $7.04 B | $6.67 B | $7.71 B | $6.53 B | -$1.69 B | $1.15 B |
| Interest Expense | $0 | -$305.00 M | $0 | $0 | $0 | -$525.00 M |
| Depreciation | $1.17 B | $1.68 B | $1.20 B | $2.68 B | $1.71 B | $1.73 B |
| Income Before Tax | $5.90 B | $5.00 B | $6.75 B | $3.42 B | -$3.53 B | -$683.00 M |
| Income Tax Expense | $818.00 M | $571.00 M | $958.00 M | $458.00 M | $709.00 M | $654.00 M |
| Net Income + | $5.08 B | $4.43 B | $5.79 B | $2.96 B | -$4.24 B | -$1.34 B |
| Net Profit Margin | 32.75% | 28.01% | 33.5% | 18.06% | -26.05% | -8.05% |
Merck & Co., Inc. Financials Balance Sheet In USD
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.79 B | $1.79 B | $1.79 B | $1.79 B | $1.79 B | $1.79 B |
| Reserve & Surplus | $68.79 B | $68.79 B | $62.66 B | $62.66 B | $59.33 B | $59.33 B |
| Non-Current Liabilities | $55.88 B | $55.88 B | $55.81 B | $55.81 B | $60.09 B | $60.09 B |
| Current Liabilities | $28.33 B | $28.33 B | $26.95 B | $26.95 B | $27.73 B | $27.73 B |
| Total Liabilities | $84.20 B | $84.20 B | $82.75 B | $82.75 B | $87.82 B | $87.82 B |
| Fixed Assets | $52.00 B | $52.00 B | $51.18 B | $51.18 B | $50.72 B | $50.72 B |
| Current Assets | $43.52 B | $43.52 B | $35.02 B | $35.02 B | $36.68 B | $36.68 B |
| Total Assets | $136.87 B | $136.87 B | $128.69 B | $128.69 B | $129.80 B | $129.80 B |
Merck & Co., Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $5.08 B | $4.43 B | $5.79 B | $2.96 B | -$4.24 B | -$1.34 B |
| Operating Cash Flow | $2.50 B | $3.29 B | $7.82 B | $2.86 B | $3.92 B | $5.37 B |
| Investing Cash Flow | -$1.49 B | -$770.00 M | -$283.00 M | -$11.20 B | -$10.21 B | -$5.60 B |
| Financing Cash Flow | -$5.75 B | -$3.56 B | $2.64 B | $4.75 B | -$2.98 B | $1.76 B |
| Change in Cash | -$4.59 B | -$659.00 M | $10.19 B | -$3.57 B | -$9.29 B | $1.49 B |
Merck & Co., Inc. Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $157.54B | -37.42% | 36.56 | 12.48% | 6.22% |
 | $63.11B | -63.61% | 0.00 | -145.16% | 0.00% |
 | $1.03T | 397.72% | 38.68 | 31.67% | 0.60% |
 | $466.55B | 148.08% | 74.67 | 6.92% | 2.62% |
 | $187.10B | 111.54% | 0.00 | 28.90% | 2.17% |
 | $128.36B | 4.23% | 13.83 | 14.64% | 4.01% |
 | $205.32B | 79.28% | 23.59 | 20.98% | 2.65% |
 | $651.20B | 64.82% | 31.33 | 28.46% | 1.98% |
 | $257.67B | 41.95% | NA | 21.11% | NA |
 | $130.87B | 173.79% | 30.04 | 32.94% | 0.00% |
Merck & Co., Inc. Return Calculator
The Merck & Co., Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$20,193
Invested Amount$10,000
Est. Returns$10,193
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Popular Stocks
FAQs
What is the share price of Merck & Co., Inc. today?
Merck & Co., Inc. (MRK) share price as of September 19, 2026 is $145.25. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Merck & Co., Inc.?
Yes, Indian Investors can invest in the Merck & Co., Inc. (MRK) Share by opening an international trading account with Angel One.
How can I purchase Merck & Co., Inc. shares in India?
Purchasing Merck & Co., Inc. (MRK) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Merck & Co., Inc. (MRK) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Merck & Co., Inc.?
Yes, you can purchase fractional shares of Merck & Co., Inc. (MRK) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Merck & Co., Inc.?
The market capitalization of Merck & Co., Inc. on September 19, 2026, is $363.04 B.
In which sector Merck & Co., Inc. belongs?
Merck & Co., Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Merck & Co., Inc. stocks?
In order to invest in Merck & Co., Inc. (MRK) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
